Inflammation & Infection

Endophthalmitis most often caused by Staphylococcus

April 17, 2014

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it. That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA.

Higher temperatures linked to severity of allergic conjunctivitis

March 14, 2014

Temperatures measured by a newly developed non-contact ocular surface thermographer (OST) can be used to evaluate the efficacy of topical anti-allergic agents because of the significant correlation of the conjunctival surface temperature and the severity of conjunctival allergic reaction, according to recently published data.

Private versus public healthcare: Is there an increased infection risk?

March 01, 2014

In this article, Dr Solborg Bjerrum discusses his recent study assessing whether there is an increased risk of post-op endophthalmitis in private clinics versus public hospitals.

Vision-threatening uveitis of unknown origin

July 01, 2013

What to investigate: aqueous, vitreous or both?

Point of care tear film test simplifies dry eye management

October 01, 2009

Diagnosing and managing dry eye patients can be challenging. Here Dr Philipp Steven looks at a new way of treating tear film osmolarity, the TearLab Osmolarity System, which he believes could dramatically simplify the process.

Clinical improvement in adenoviral conjunctivitis model

July 15, 2009

Foresight Biotherapeutics, Inc. has announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis.

Liquid ocular bandage launched in Europe

March 25, 2009

BD OcuSeal Liquid Ocular Bandage, a fully synthetic protective barrier to be used for post-surgical, post-traumatic and non-traumatic ocular conditions, has been launched in Europe by BD Medical?Ophthalmic Systems.

Novagali technologies allow greater drug access to the posterior of the eye

March 25, 2009

According to research analysts it is estimated that as little as five percent of a topically applied drug ever reaches the intraocular tissues due to drug loss as the result of tearing, lacrimal fluid-eye barriers, and blood-ocular barriers.

Retisert implant in sympathetic ophthalmia

March 18, 2009

The fluocinolone acetonide (Retisert; Bausch & Lomb) surgical implant can prevent blindness in cases of sympathetic ophthalmia (SO), according to research at the University of Iowa, US.

Link between skin cancer and eye cancer

March 11, 2009

There is an association between uveal and a variety of skin melanomas, according to study results published in the March issue of Ophthalmology.